Cardioversion procedure for atrial fibrillation patients revealing the costs associated with warfarin compared to the new oral anticoagulants (NOAC).

Ann Kirby; Aileen Murphy; M. O'Shea; G. Allen; G. Fahy

Cardioversion procedure for atrial fibrillation patients revealing the costs associated with warfarin compared to the new oral anticoagulants (NOAC).

Ann Kirby
, Aileen Murphy
, M. O'Shea
, G. Allen
, G. Fahy

Cork University Business School

Research output: Contribution to conference › Abstract › peer-review

Original language	English (Ireland)
Publication status	Published - Jul 2015
Event	International Health Economics Association. Milan. Italy - Duration: 12 Jul 2015 → 15 Jul 2015

Conference

Conference	International Health Economics Association. Milan. Italy
Period	12/07/15 → 15/07/15

Cite this

@conference{9569ed1a7286441db4647999d0192309,

title = "Cardioversion procedure for atrial fibrillation patients revealing the costs associated with warfarin compared to the new oral anticoagulants (NOAC).",

author = "Ann Kirby and Aileen Murphy and M. O'Shea and G. Allen and G. Fahy",

year = "2015",

month = jul,

language = "English (Ireland)",

note = "International Health Economics Association. Milan. Italy ; Conference date: 12-07-2015 Through 15-07-2015",

}

TY - CONF

T1 - Cardioversion procedure for atrial fibrillation patients revealing the costs associated with warfarin compared to the new oral anticoagulants (NOAC).

AU - Kirby, Ann

AU - Murphy, Aileen

AU - O'Shea, M.

AU - Allen, G.

AU - Fahy, G.

PY - 2015/7

Y1 - 2015/7

M3 - Abstract

T2 - International Health Economics Association. Milan. Italy

Y2 - 12 July 2015 through 15 July 2015

ER -